Status:
RECRUITING
Central Vein Stenosis Due to Dialysis Catheter Insertion in Subclavian Compared to Jugular Vein
Lead Sponsor:
Skane University Hospital
Conditions:
Subclavian Vein Stenosis
Jugular Vein Occlusion
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Central vein stenosis (CVS) is a well-known complication of central venous catheterization, especially after insertion of temporary hemodialysis catheters (tHDC). Incidence and prevalence differ betwe...
Detailed Description
This is a multicentric, prospective, randomized, controlled, assessor-blinded, non-inferiority trial. Patients will be enrolled in three hospitals (Lund, Malmö, Helsingborg) in southern Sweden. The tr...
Eligibility Criteria
Inclusion
- Adults (18 years of age or older).
- In need of a tCDC with an expected treatment time of at least 7 days.
- Informed consent.
Exclusion
- Intravenous pacemaker or a PICC-line via right-sided central veins in situ.
- Known right-sided CVS.
- AV fistula on the right upper extremity.
- History of central venous vascular interventions including stents, dilatations and more (but not previous central venous catheterization).
- Central venous catheter in the right internal jugular vein or in the right subclavian vein in situ.
- Either the right jugular vein or the right subclavian vein unavailable for catheterization due to, e.g., local skin infection, thrombosis or inability to visualize the vein with ultrasound.
- Known allergy to iodinated contrast agents.
- BMI \>35 kg/m2.
- No study physician available for the catheterization.
Key Trial Info
Start Date :
November 15 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2025
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04871568
Start Date
November 15 2021
End Date
December 31 2025
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Skånes universitetssjukhus
Lund, Sweden, 22185